"UPMC Hillman Cancer Center - Washington (Medical Oncology) is a Cancer Treatment Center located in Washington.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Cancer Center-Washington conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 10 clinical trials were completed, i.e. on average, 43.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Cancer Center-Washington" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored, "University of Pittsburgh" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Cancer Center-Washington" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Cancer Center-Washington" are "Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials), "Prostate Cancer" (3 trials), "Stage IIIB Lung Cancer AJCC v8" (3 trials), "Stage IV Lung Cancer AJCC v8" (3 trials) and "Adenoid Cystic Carcinoma" (2 trials). Many other conditions were trialed in "UPMC Cancer Center-Washington" in a lesser frequency.

Most popular intervention types in "UPMC Cancer Center-Washington" are "Drug" (30 trials), "Procedure" (11 trials), "Biological" (10 trials), "Other" (10 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (8 trials), "Computed Tomography" (8 trials), "Biospecimen Collection" (6 trials), "Paclitaxel" (6 trials) and "Magnetic Resonance Imaging" (5 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Cancer Center-Washington" are 27 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Cancer Center-Washington". undefined are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in UPMC Cancer Center-Washington, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Cancer Center-Washington, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".